Vitalhub (TSE:VHI – Get Free Report) had its price target cut by stock analysts at National Bank Financial from C$14.00 to C$11.00 in a research note issued to investors on Wednesday,BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. National Bank Financial’s price target points to a potential upside of 48.05% from the company’s current price.
A number of other research firms also recently weighed in on VHI. Raymond James Financial dropped their price target on Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 24th. Scotiabank dropped their price target on Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th. Finally, ATB Cormark Capital Markets dropped their price target on Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 10th. One equities research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of C$13.14.
Vitalhub Price Performance
Vitalhub (TSE:VHI – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported C$0.04 earnings per share for the quarter. Vitalhub had a return on equity of 2.98% and a net margin of 6.13%.The business had revenue of C$31.91 million for the quarter. Equities research analysts anticipate that Vitalhub will post 0.2296467 earnings per share for the current year.
Insider Buying and Selling
In other Vitalhub news, Director Francis Nelson Shen purchased 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 26th. The stock was bought at an average cost of C$6.99 per share, with a total value of C$349,500.00. Following the completion of the transaction, the director owned 50,000 shares of the company’s stock, valued at C$349,500. The trade was a ∞ increase in their position. Also, Director Anthony Pius Shen purchased 7,000 shares of the firm’s stock in a transaction that occurred on Monday, March 30th. The shares were acquired at an average cost of C$7.11 per share, with a total value of C$49,770.00. Following the completion of the transaction, the director directly owned 12,470 shares of the company’s stock, valued at C$88,661.70. The trade was a 127.97% increase in their position. Insiders have purchased 496,600 shares of company stock valued at $3,476,470 over the last ninety days. 18.57% of the stock is currently owned by company insiders.
About Vitalhub
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Read More
- Five stocks we like better than Vitalhub
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
- Zscaler Stock Drops 30%: Why the Dip Is a Buy Opportunity
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
